Montaner, Joan
Universitat Autònoma de Barcelona · Hospital Universitario Virgen Macarena · Vall d'Hebron Institut de Recerca · Instituto de Biomedicina de Sevilla · Hospital Universitario Virgen del Rocío · Universidad de Sevilla
13 papers on CoChatORCID 0000-0003-4845-2279
Most cited papers
- Verified
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
Charidimou, A., Boulouis, G., Frosch, M. P., Baron, J.-C., Pasi, M., Albucher, J. F., Banerjee, G., Barbato, C., Bonneville, F., Brandner, S., et al. (2022) · The Lancet Neurology
Intracerebral and Subarachnoid Hemorrhage ResearchCerebrovascular and genetic disorders
Cited by 723
- Verified
Meta-analysis of Genome-wide Association Studies Identifies 1q22 as a Susceptibility Locus for Intracerebral Hemorrhage
Woo, D., Falcone, G. J., Devan, W. J., Brown, W. M., Biffi, A., Howard, T. D., Anderson, C. D., Brouwers, H. B., Valant, V., Battey, T. W. K., et al. (2014) · The American Journal of Human Genetics
Intracerebral and Subarachnoid Hemorrhage ResearchGenetic Associations and Epidemiology
Cited by 290
- Verified
Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial
Elkins, J., Veltkamp, R., Montaner, J., Johnston, S. C., Singhal, A. B., Becker, K., Lansberg, M. G., Tang, W., Chang, I., Muralidharan, K., et al. (2017) · The Lancet Neurology
Acute Ischemic Stroke ManagementNeuroinflammation and Neurodegeneration Mechanisms
Cited by 224
- Verified
ADAMTS proteoglycanases in the physiological and pathological central nervous system.
Lemarchant, S., Pruvost, M., Montaner, J., Emery, E., Vivien, D., Kanninen, K., & Koistinaho, J. (2013) · Journal of Neuroinflammation
Proteoglycans and glycosaminoglycans researchProtease and Inhibitor Mechanisms
Cited by 96
- Verified
The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology
Lemmens, R., Buysschaert, I., Geelen, V., Fernandez-Cadenas, I., Montaner, J., Schmidt, H., Schmidt, R., Attia, J., Maguire, J., Levi, C., et al. (2010) · Stroke
Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management
Cited by 77
- Verified
Automated quantification of cerebral edema following hemispheric infarction: application of a machine-learning algorithm to evaluate CSF shifts on serial head CTs
Chen, Y., Dhar, R., Heitsch, L., Ford, A., Fernandez-Cadenas, I., Carrera, C., Montaner, J., Lin, W., Shen, D., An, H., et al. (2016) · NeuroImage: Clinical
Medical Image Segmentation TechniquesAcute Ischemic Stroke Management
Cited by 74
- Verified
Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome
Heitsch, L., Ibanez, L., Carrera, C., Binkley, M. M., Strbian, D., Tatlisumak, T., Bustamante, A., Ribó, M., Molina, C., Dávalos, A., et al. (2021) · Stroke
Acute Ischemic Stroke ManagementIntracerebral and Subarachnoid Hemorrhage Research
Cited by 70
- Verified
Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis
Marini, S., Crawford, K., Morotti, A., Lee, M. J., Pezzini, A., Moomaw, C. J., Flaherty, M. L., Montaner, J., Roquer, J., Jimenez-Conde, J., et al. (2019) · JAMA Neurology
Intracerebral and Subarachnoid Hemorrhage ResearchGenetic Associations and Epidemiology
Cited by 68
- Verified
Modulation of Amyloid-β1–40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier
Merino-Zamorano, C., Fernández-de Retana, S., Montañola, A., Batlle, A., Saint-Pol, J., Mysiorek, C., Gosselet, F., Montaner, J., & Hernández-Guillamon, M. (2016) · Journal of Alzheimer's Disease
Alzheimer's disease research and treatmentsBarrier Structure and Function Studies
Cited by 63
- Verified
Assessment of enlarged perivascular spaces and their relation to target organ damage and mild cognitive impairment in patients with hypertension
Riba‐Llena, I., Nafría, C., Mundet, X., López‐Rueda, A., Fernández‐Cortiñas, I., Jarca, C. I., Jiménez‐Balado, J., Domingo, M., Tovar, J. L., Orfila, F., et al. (2016) · European Journal of Neurology
Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research
Cited by 25
- Verified
Overlap in the Genetic Architecture of Stroke Risk, Early Neurological Changes, and Cardiovascular Risk Factors
Ibanez, L., Heitsch, L., Dube, U., Farias, F. H. G., Budde, J., Bergmann, K., Davenport, R., Bradley, J., Carrera, C., Kinnunen, J., et al. (2019) · Stroke
Genetic Associations and EpidemiologyAcute Ischemic Stroke Management
Cited by 23
- Verified
The UCP2-866G/A Polymorphism Could be Considered as a Genetic Marker of Different Functional Prognosis in Ischemic Stroke after Recanalization
Díaz-Maroto Cicuéndez, I., Fernández-Díaz, E., García-García, J., Jordán, J., Fernández-Cadenas, I., Montaner, J., Serrano-Heras, G., & Segura, T. (2017) · NeuroMolecular Medicine
Acute Ischemic Stroke ManagementNeuroprotection in Cerebral Ischemia
Cited by 12
- Verified
Elevated Brain Tissue miR-223-3p After Ischemic Stroke Reflects Immune Infiltration Rather Than Intrinsic Upregulation
Korvenlaita, N., Gómez-Budia, M., Pistono, C., Scoyni, F., Jäntti, H., Ohtonen, S., Fazaludeen, M. F., de Sande, A. H., Bouvy-Liivrand, M., Heinäniemi, M., et al. (2026) · Cellular and Molecular Neurobiology
Neuroinflammation and Neurodegeneration MechanismsMicroRNA in disease regulation
Cited by 0
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free